Immunotherapy in Tumors: Treatments, Complications and Diagnostic Evaluation of Response
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 May 2024 | Viewed by 1453
Special Issue Editor
Interests: oncologic imaging; CT; ultrasound; MRI; melanoma; cancer immunotherapy; head and neck cancer; sarcoma; soft tissue tumors; thyroid cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Immunotherapy is a powerful treatment of tumors by activating or suppressing the immune system. Cell-based immunotherapies are effective for many cancers. Immunotherapy research has attracted much attention due to its potential to treat various cancers. To deepen the understanding of functioning mechanism of various types of immunotherapy and immunotherapy-related complications, this Special Issue titled “Immunotherapy in Tumors: Treatments, Complications and Diagnostic Evaluation of Response” aims to collect the latest original recent articles and reviews describing the molecular aspects of Immunotherapy and complications, including but not limited to the following areas:
- Cancer Immunotherapy;
- Immune checkpoint inhibitor;
- complications;
- potential side-effects;
- Immune Response.
Dr. Fabio Sandomenico
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer immunotherapy
- immune checkpoint inhibitor
- complications
- potential side-effects
- immune response
